Gtf2H1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
:: infobox .infobox-gene
| Gene Symbol | GTF2H1 |
| Full Name | General Transcription Factor IIH Subunit 1 |
| Chromosomal Location | 11q13.1 |
| NCBI Gene ID | 2965 |
| OMIM | 189903 |
| Ensembl ID | ENSG00000110768 |
| UniProt | P32780 |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Cockayne Syndrome |
::
GTF2H1 (General Transcription Factor IIH Subunit 1) encodes the largest and most essential subunit of the TFIIH complex, which is required for both RNA polymerase II transcription initiation and nucleotide excision repair (NER). TFIIH possesses ATP-dependent helicase and kinase activities that are critical for opening DNA around transcription or repair intermediates. GTF2H1 dysfunction leads to severe neurological phenotypes, including premature aging disorders and increased neurodegeneration risk.
GTF2H1 is the largest subunit of the general transcription factor IIH (TFIIH) complex, which is essential for both transcription initiation and nucleotide excision repair (NER). TFIIH has ATP-dependent helicase activity that unwinds DNA around lesions during NER 1.
In neurons, GTF2H1 and the TFIIH complex are important for repairing UV-induced DNA damage and bulky adducts that cannot be repaired by other pathways. The NER pathway is particularly important for neurons due to their long lifespan and constant exposure to genotoxic stress.
GTF2H1 dysfunction may contribute to the accumulation of DNA damage in AD neurons. Transcription-coupled NER is important for maintaining neuronal gene expression 2.
Dopaminergic neurons may be particularly vulnerable to defects in DNA repair pathways including NER. GTF2H1 variants have been implicated in PD risk 3.
GTF2H1 mutations can cause Cockayne syndrome, a premature aging disorder with severe neurodegeneration. This highlights the importance of TFIIH-mediated DNA repair in the nervous system.
GTF2H1 is expressed in all brain regions, with high expression in the hippocampus and cerebral cortex. Expression is essential in all cell types.
The study of Gtf2H1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.